Insider Transactions in Q1 2025 at Protara Therapeutics, Inc. (TARA)
Insider Transaction List (Q1 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 24
2025
|
Patrick Fabbio Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
23,500
+34.06%
|
-
|
|
Jan 24
2025
|
Hannah Fry VP, Controller |
BUY
Grant, award, or other acquisition
|
Direct |
9,500
+19.61%
|
-
|
|
Jan 24
2025
|
Jacqueline Zummo Chf Scientific Operations Off |
BUY
Grant, award, or other acquisition
|
Direct |
24,500
+16.21%
|
-
|
|
Jan 24
2025
|
Jesse Shefferman CEO and President |
BUY
Grant, award, or other acquisition
|
Direct |
65,000
+6.14%
|
-
|
|
Jan 21
2025
|
Jacqueline Zummo Chf Scientific Operations Off |
SELL
Payment of exercise price or tax liability
|
Direct |
6,554
-6.42%
|
$26,216
$4.76 P/Share
|
|
Jan 21
2025
|
Hannah Fry VP, Controller |
SELL
Payment of exercise price or tax liability
|
Direct |
2,130
-7.23%
|
$8,520
$4.76 P/Share
|
|
Jan 21
2025
|
Patrick Fabbio Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,061
-13.91%
|
$12,244
$4.76 P/Share
|
|
Jan 21
2025
|
Jesse Shefferman CEO and President |
SELL
Payment of exercise price or tax liability
|
Direct |
15,469
-1.67%
|
$61,876
$4.76 P/Share
|
|
Jan 03
2025
|
Hannah Fry VP, Controller |
SELL
Payment of exercise price or tax liability
|
Direct |
394
-1.32%
|
$2,364
$6.14 P/Share
|
|
Jan 03
2025
|
Jacqueline Zummo Chf Scientific Operations Off |
SELL
Payment of exercise price or tax liability
|
Direct |
2,157
-2.07%
|
$12,942
$6.14 P/Share
|
|
Jan 03
2025
|
Jesse Shefferman CEO and President |
SELL
Payment of exercise price or tax liability
|
Direct |
6,479
-0.69%
|
$38,874
$6.14 P/Share
|